Allay Therapeutics (Series D)
Funding Details
- Awarder
- Inbox
- Date Award
- June 05, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $57,500,000
Company Info
- Company Description
- Allay Therapeutics is a clinical-stage biotechnology company providing ultra-sustained analgesic products for post-surgical pain management and recuperation. Its proprietary technology platform combines validated non-opioid analgesics and biopolymers to create dissolvable candidates to deliver pain relief within a targeted site over weeks.
- Market
- Post-surgical pain management
- Location
- San Jose, California, USA
- Coinvestors
- Lightstone Ventures, ClavystBio, NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare, Brandon Capital, IPD Capital, EDBI, SGInnovate, HSBC Innovation Banking